Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Crohn's disease genotypes of patients in remission vs relapses after infliximab discontinuation.

World journal of gastroenterology - 28 Sept 2012

Lu Cathy, Waugh Alistair, Bailey Robert J, Cherry Raeleen, Dieleman Levinus A, Gramlich Leah, Matic Kata, Millan Mario, Kroeker Karen I, Sadowski Daniel, Teshima Christopher W, Todoruk Dennis, Wong Clarence, Wong Karen, Fedorak Richard N

Abstract excerpt

AIM: To investigate genetic differences between Crohn's disease (CD) patients with a sustained remission vs relapsers after discontinuing infliximab while in corticosteroid-free remission. METHODS: Forty-eight CD patients received infliximab and were in full corticosteroid-free clinical remission but then discontinued infliximab for reasons other than a loss of response, were identified by review of an electronic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Antibodies, Monoclonal

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Crohn Disease

Share to Infliximab

Share to Nod2 Signaling Adaptor Protein

Share to Polymorphism, Single Nucleotide

Share to Recurrence

Share to Tumor Necrosis Factor-alpha

Source

Open in PubMed Open full text

Identifiers

PMID: 23049214
DOI: 10.3748/wjg.v18.i36.5058
PMCID: PMC3460332

Genes

NOD2

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Crohn's disease genotypes of patients in remission vs relapses after infliximab discontinuation.PMID 23049214Read ↗

Response to infliximab treatment in Crohn's disease is not associated with mutations in the CARD15 (NOD2) gene: an analysis in 534 patients from two multicenter, prospective GCP-level trials.Semantic proximity Read ↗

NOD2/CARD15 does not influence response to infliximab in Crohn's disease.Semantic proximity Read ↗

Clinical and Genetic Factors Impact Time to Surgical Recurrence After Ileocolectomy for Crohn's Disease.Semantic proximity Read ↗

CARD8 gene variant is a risk factor for recurrent surgery in patients with Crohn's disease.Semantic proximity Read ↗

Assessment of the Influence of Inflammation and FCGR3A Genotype on Infliximab Pharmacokinetics and Time to Relapse in Patients with Crohn's Disease.Semantic proximity Read ↗

Single nucleotide polymorphisms in ADAM17, IL23R and SLCO1C1 genes protect against infliximab failure in adults with Crohn's disease.Semantic proximity Read ↗

Single nucleotide polymorphisms in the NOD2/CARD15 gene are associated with an increased risk of relapse and death for patients with acute leukemia after hematopoietic stem-cell transplantation with unrelated donors.Semantic proximity Read ↗

Contribution of susceptibility variants at FCGR2A and 13q12 to the risk of relapse among Japanese patients with ulcerative colitis.Semantic proximity Read ↗

HLA-DQA1*05 and upstream variants of PPARGC1B are associated with infliximab persistence in Japanese Crohn’s disease patientsSemantic proximity Read ↗

Decreased Infliximab Concentrations in Patients With Inflammatory Bowel Disease Who Carry a Variable Number Tandem Repeat Polymorphism in the Neonatal Fc Receptor or Variant HLADQA1*05G>A Genotype.Semantic proximity Read ↗

HLADQA1*05 genotype predicts anti-drug antibody formation and loss of response during infliximab therapy for inflammatory bowel disease.Semantic proximity Read ↗

Matrix metalloproteinases and their tissue inhibitors as prognostic indicators for diagnostic and surgical recurrence in Crohn's disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.